FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to derivatives of pyrazole of the general formula (I) where means phenyl substituted with cyclo(lower)alkyl, hydroxy(lower)alkyl, cyano-, lower alkylenedihydroxy-, carboxy-, (lower alkoxy)carbonyl-group, lower alkanoyl, lower alkanoylhydroxy-, lower alkoxy-, phenoxy-group or carbamoyl optionally substituted with lower alkyl; R2 means halogen, halo(lower)alkyl, cyano-, carboxy-, (lower alkoxy)carbonyl- -group, carbamoyl optionally substituted with alkyl; R3 means phenyl substituted with lower alkylthio-group, lower alkylsulfinyl- or lower alkylsulfonyl-group at condition that if R1 means phenyl substituted with lower alkoxy-group then R2 means halogen or halo(lower)alkyl, or their pharmaceutically acceptable salts. Synthesized compounds show antiinflammatory, antirheumatic and analgetic activity. EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 4 cl, 5 dwg, 3 tbl, 33 ex
Title |
Year |
Author |
Number |
METHOD OF SYNTHESIS OF PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1990 |
- Matsuo Masaaki[Jp]
- Tsudzi Kiesi[Jp]
- Konisi Nobukie[Jp]
- Nakamura Katsuja[Jp]
|
RU2021990C1 |
CEPHEM COMPOUNDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1992 |
- Kazuo Sakane[Jp]
- Kokhdzi Kavabata[Jp]
- Kenzi Mijaj[Jp]
- Esikhiko Inamoto[Jp]
|
RU2081874C1 |
POLYPEPTIDE COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF PROPHYLAXIS AND/OR THERAPEUTIC TREATMENT |
1994 |
- Khidenori Okhki
- Masaki Tomisima
- Akira Jamada
- Khisasi Takasugi
|
RU2164230C2 |
HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND INTERMEDIATE COMPOUNDS |
1994 |
- Taniguti Kiesi
- Nagano Masanobu
- Khattori Kojudzi
- Tsubaki Kazunori
- Okitsu Osamu
- Tabuti Sejitiro
|
RU2176640C2 |
DERIVATIVES OF N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE AS ANTAGONISTS OF PLATELET ACTIVATION FACTOR, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |
1994 |
- Mitsuru Okhkubo
- Fumie Takakhasi
- Tosio Jamanaka
- Khiroesi Sakai
- Masajuki Kato
|
RU2161155C2 |
CYCLOPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHODS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1991 |
- Tosiro Ivamoto[Jp]
- Akikhiko Fudzie[Jp]
- Kumiko Nitta[Jp]
- Jasukhisa Tsurumi[Jp]
- Nobukharu Sigematsu[Jp]
- Tijosi Kasakhara[Jp]
- Motokhiro Khino[Jp]
- Masakuni Okukhara[Jp]
- Kazuo Sakane[Jp]
- Kokhdzi Kavabata[Jp]
- Khidenori Okhki[Jp]
|
RU2108342C1 |
PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF TACHYKININ EFFECT |
1993 |
- Masaaki Matsuo
- Dajdzhiro Khagivara
- Khirosi Mijake
|
RU2119922C1 |
POLYPEPTIDE COMPOUND, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1995 |
- Khidenori Oki
- Masaki Tomisima
- Akira Jamada
- Khizasi Takazugi
|
RU2165423C2 |
1,2,3,4-TETRAHYDROPYRAZOLO-[5,1-C]-(1,2,4)-TRIAZINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION INHIBITING PRODUCING AN INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR, METHOD OF PROPHYLACTIC OR THERAPEUTIC TREATMENT OF PATIENTS WITH DISEASES MEDIATED BY INTERLEUKIN AND TUMOR NECROSIS FACTOR |
1994 |
- Esio Kavai
- Khitosi Jamazaki
- Khirokazu Tanaka
- Teruo Oku
|
RU2124517C1 |
GUANIDINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND METHOD FOR INHIBITING Na/H EXCHANGE IN CELLS |
1994 |
- Atsusi Kuno
- Josikazu Inou
- Khisasi Takasugi
- Khiroaki Mizuno
- Kumi Jamasaki
|
RU2141946C1 |